Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Assurex Health Inc.

www.assurerxhealth.com

Latest From Assurex Health Inc.

Device/Diagnostics Quarterly Deal Statistics, Q3 2016

Q3 medtech financing doubled in dollar volume to $3 billion, with debt offerings again representing the majority of the aggregate; acquisitions totaled $5.3 billion, mainly due to Johnson & Johnson’s $4.3 billion buy of Abbott Medical Optics. Diagnostics financings, which brought in $85 million, continued to decline, but at $5 billion, acquisitions showed a slight increase over the previous quarter, with Danaher’s takeover of Cepheid accounting for most of the M&A volume.

Market Intelligence Deals

Deals Shaping the Medical Industry, September 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in August 2016.

Deals BioPharmaceutical

August M&A Analysis: Slow Month Highlighted By Unique Technologies

The dog-days of summer produced just a handful of mergers and acquisitions in the medtech sector and no blockbuster deals. However, several companies made smaller deals for innovative products in a range of sectors including IVDs, cardiovascular devices, and ophthalmology.

Commercial Companies

Myriad To Enter Neuroscience Market With $225m Assurex Acquisition

In its bid to develop more targeted diagnostics and build future partnerships with pharma companies, Myriad has signed a $225m deal, plus milestones, to acquire Assurex Health.

Commercial Deals
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
    • Pharmacogenetics-Pharmacogenomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • AssureRx Health Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Assurex Health Inc.
  • Senior Management
  • Virginia C Drosos, Pres. & CEO
    Donato L Peter , SVP & CFO
    Mark S Verratti, SVP, Chief Sales & Business Dev. Officer
    Bryan M Dechairo, PhD, SVP, Med. Affairs & Clin. Dev.
    Donald R Wright, EVP & COO
    Jeff P Borcherding, VP, Mktg.
    Scott M Roth, VP, Product Dev.
  • Contact Info
  • Assurex Health Inc.
    Phone: (888) 987-9913
    6030 S. Mason-Montgomery Rd.
    Mason, OH 45040
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register